The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

18F Fluorodeoxyglucose     (2R,3S,4R,5R)-2-fluoro- 3,4,5,6...

Synonyms: CHEMBL1808698, CHEBI:49136, AC1L2A3S, 63503-12-8, 100343-74-6, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fludeoxyglucose F 18


Psychiatry related information on Fludeoxyglucose F 18


High impact information on Fludeoxyglucose F 18


Chemical compound and disease context of Fludeoxyglucose F 18


Biological context of Fludeoxyglucose F 18


Anatomical context of Fludeoxyglucose F 18


Associations of Fludeoxyglucose F 18 with other chemical compounds


Gene context of Fludeoxyglucose F 18


Analytical, diagnostic and therapeutic context of Fludeoxyglucose F 18


  1. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lewis, P., Griffin, S., Marsden, P., Gee, T., Nunan, T., Malsey, M., Dussek, J. Lancet (1994) [Pubmed]
  2. Imaging of hepatoma with 18F-fluorodeoxyglucose. Paul, R., Ahonen, A., Roeda, D., Nordman, E. Lancet (1985) [Pubmed]
  3. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Skehan, S.J., Issenman, R., Mernagh, J., Nahmias, C., Jacobson, K. Lancet (1999) [Pubmed]
  4. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow, R.O., Dilsizian, V., Cuocolo, A., Bacharach, S.L. Circulation (1991) [Pubmed]
  5. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Weihrauch, M.R., Re, D., Scheidhauer, K., Ansén, S., Dietlein, M., Bischoff, S., Bohlen, H., Wolf, J., Schicha, H., Diehl, V., Tesch, H. Blood (2001) [Pubmed]
  6. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Kuhl, D.E., Phelps, M.E., Markham, C.H., Metter, E.J., Riege, W.H., Winter, J. Ann. Neurol. (1982) [Pubmed]
  7. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., Hashimoto, M., Hirono, N., Shimomura, T., Mori, E. Neurology (1998) [Pubmed]
  8. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Goldman, S., Laird, A., Flament-Durand, J., Luxen, A., Bidaut, L.M., Stanus, E., Hildebrand, J., Przedborski, S. Neurology (1993) [Pubmed]
  9. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Minoshima, S., Frey, K.A., Koeppe, R.A., Foster, N.L., Kuhl, D.E. J. Nucl. Med. (1995) [Pubmed]
  10. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Sultzer, D.L., Mahler, M.E., Cummings, J.L., Van Gorp, W.G., Hinkin, C.H., Brown, C. Arch. Neurol. (1995) [Pubmed]
  11. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution. Marin-Neto, J.A., Dilsizian, V., Arrighi, J.A., Freedman, N.M., Perrone-Filardi, P., Bacharach, S.L., Bonow, R.O. Circulation (1993) [Pubmed]
  12. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake. Vanoverschelde, J.L., Melin, J.A., Bol, A., Vanbutsele, R., Cogneau, M., Labar, D., Robert, A., Michel, C., Wijns, W. Circulation (1992) [Pubmed]
  13. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P., Fillet, G. Blood (1999) [Pubmed]
  14. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Lapela, M., Leskinen, S., Minn, H.R., Lindholm, P., Klemi, P.J., Söderström, K.O., Bergman, J., Haaparanta, M., Ruotsalainen, U., Solin, O., Joensuu, H. Blood (1995) [Pubmed]
  15. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. Gropler, R.J., Siegel, B.A., Sampathkumaran, K., Pérez, J.E., Sobel, B.E., Bergmann, S.R., Geltman, E.M. J. Am. Coll. Cardiol. (1992) [Pubmed]
  16. Glucose uptake by gliomas after treatment. A positron emission tomographic study. Rozental, J.M., Levine, R.L., Nickles, R.J., Dobkin, J.A. Arch. Neurol. (1989) [Pubmed]
  17. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. Kaschten, B., Stevenaert, A., Sadzot, B., Deprez, M., Degueldre, C., Del Fiore, G., Luxen, A., Reznik, M. J. Nucl. Med. (1998) [Pubmed]
  18. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium. Tsubokawa, A., Lee, J.D., Shimizu, H., Nakano, A., Uzui, H., Takeuchi, M., Tsuchida, T., Yonekura, Y., Ishii, Y., Ueda, T. J. Nucl. Med. (1997) [Pubmed]
  19. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. Gropler, R.J., Geltman, E.M., Sampathkumaran, K., Pérez, J.E., Moerlein, S.M., Sobel, B.E., Bergmann, S.R., Siegel, B.A. J. Am. Coll. Cardiol. (1992) [Pubmed]
  20. Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography. Cornel, J.H., Bax, J.J., Fioretti, P.M., Visser, F.C., Maat, A.P., Boersma, E., van Lingen, A., Elhendy, A., Roelandt, J.R. Eur. Heart J. (1997) [Pubmed]
  21. A mathematical model for the distribution of fluorodeoxyglucose in humans. Hays, M.T., Segall, G.M. J. Nucl. Med. (1999) [Pubmed]
  22. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia. Yokoyama, I., Ohtake, T., Momomura, S., Yonekura, K., Kobayakawa, N., Aoyagi, T., Sugiura, S., Yamada, N., Ohtomo, K., Sasaki, Y., Omata, M., Yazaki, Y. J. Nucl. Med. (1999) [Pubmed]
  23. Feasibility of planar fluorine-18-FDG imaging after recent myocardial infarction to assess myocardial viability. Huitink, J.M., Visser, F.C., van Lingen, A., Groeneveld, A.B., Bax, J.J., van Leeuwen, G.R., Visser, G.M., Van Loon, M.J., Teule, G.J., Visser, C.A. J. Nucl. Med. (1995) [Pubmed]
  24. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Camici, P., Araujo, L.I., Spinks, T., Lammertsma, A.A., Kaski, J.C., Shea, M.J., Selwyn, A.P., Jones, T., Maseri, A. Circulation (1986) [Pubmed]
  25. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. Pozo-Rodríguez, F., Martín de Nicolás, J.L., Sánchez-Nistal, M.A., Maldonado, A., García de Barajas, S., Calero-García, R., Pozo, M.A., Martín-Escribano, P., Martín-García, I., García-Lujan, R., Lopez-Encuentra, A., Arenas de Pablo, A. J. Clin. Oncol. (2005) [Pubmed]
  26. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Engel, J., Brown, W.J., Kuhl, D.E., Phelps, M.E., Mazziotta, J.C., Crandall, P.H. Ann. Neurol. (1982) [Pubmed]
  27. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. Grigsby, P.W., Siegel, B.A., Dehdashti, F., Rader, J., Zoberi, I. J. Clin. Oncol. (2004) [Pubmed]
  28. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. Perrone-Filardi, P., Bacharach, S.L., Dilsizian, V., Marin-Neto, J.A., Maurea, S., Arrighi, J.A., Bonow, R.O. J. Am. Coll. Cardiol. (1994) [Pubmed]
  29. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose. Matsunari, I., Böning, G., Ziegler, S.I., Nekolla, S.G., Stollfuss, J.C., Kosa, I., Ficaro, E.P., Schwaiger, M. J. Am. Coll. Cardiol. (1998) [Pubmed]
  30. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. Mann, J.J., Malone, K.M., Diehl, D.J., Perel, J., Nichols, T.E., Mintun, M.A. J. Cereb. Blood Flow Metab. (1996) [Pubmed]
  31. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. Tamaki, N., Ohtani, H., Yamashita, K., Magata, Y., Yonekura, Y., Nohara, R., Kambara, H., Kawai, C., Hirata, K., Ban, T. J. Nucl. Med. (1991) [Pubmed]
  32. Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique. Merlet, P., Mazoyer, B., Hittinger, L., Valette, H., Saal, J.P., Bendriem, B., Crozatier, B., Castaigne, A., Syrota, A., Randé, J.L. J. Nucl. Med. (1993) [Pubmed]
  33. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). Fukuchi, K., Nozaki, S., Yoshizumi, T., Hasegawa, S., Uehara, T., Nakagawa, T., Kobayashi, T., Tomiyama, Y., Yamashita, S., Matsuzawa, Y., Nishimura, T. J. Nucl. Med. (1999) [Pubmed]
  34. The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake. Wolf, G., Aigner, R.M., Schaffler, G., Langsenlehner, U., Renner, W., Samonigg, H., Yazdani-Biuki, B., Krippl, P. Breast Cancer Res. Treat. (2004) [Pubmed]
  35. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. Findlay, M., Young, H., Cunningham, D., Iveson, A., Cronin, B., Hickish, T., Pratt, B., Husband, J., Flower, M., Ott, R. J. Clin. Oncol. (1996) [Pubmed]
  36. Verbal memory in left temporal lobe epilepsy: evidence for task-related localization. Weintrob, D.L., Saling, M.M., Berkovic, S.F., Berlangieri, S.U., Reutens, D.C. Ann. Neurol. (2002) [Pubmed]
  37. Imaging the metabolic footprint of Glut1 deficiency on the brain. Pascual, J.M., Van Heertum, R.L., Wang, D., Engelstad, K., De Vivo, D.C. Ann. Neurol. (2002) [Pubmed]
  38. Cancer screening with whole-body 18F-fluorodeoxyglucose positron-emission tomography. Yasuda, S., Shohtsu, A. Lancet (1997) [Pubmed]
  39. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Tamaki, N., Kawamoto, M., Tadamura, E., Magata, Y., Yonekura, Y., Nohara, R., Sasayama, S., Nishimura, K., Ban, T., Konishi, J. Circulation (1995) [Pubmed]
  40. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Lee, S.K., Lee, S.Y., Kim, K.K., Hong, K.S., Lee, D.S., Chung, C.K. Ann. Neurol. (2005) [Pubmed]
  41. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. Choi, J.Y., Lee, K.S., Kwon, O.J., Shim, Y.M., Baek, C.H., Park, K., Lee, K.H., Kim, B.T. J. Clin. Oncol. (2005) [Pubmed]
WikiGenes - Universities